The hilarious folks at Screen Junkies, who make “honest” trailers of Hollywood’s biggest hits have just aimed their arrows at Frozen, your favorite soon-to-be-Broadway show ever. We can’t even describe how genius the video below is. Just click and watch it already! View Comments
Oct 5, 2009 (CIDRAP News) – The nation’s first doses of the pandemic H1N1 vaccine were administered today, mainly to a limited group of healthcare workers and emergency medical service workers, while some physicians’ offices fielded calls about when the vaccine would be more widely available.Federal, state, and local officials were on hand to witness the events today at medical facilities in Memphis and Indianapolis. The very first doses were given to healthcare workers at Le Bonheur Children’s Medical Center in Memphis, according to a press release from the hospital.Doctors, nurses, and respiratory therapists who work in the hospital’s emergency department and intensive care units were in the first group to receive the live attenuated nasal mist form of the H1N1 flu vaccine, made by MedImmune. Pediatric physicians, residents, and infectious disease specialists were also among Le Bonheur’s first recipients.About 150 workers lined up to receive the vaccine.The US Centers for Disease Control and Prevention (CDC) has singled out healthcare workers as the top priority group to receive the vaccine when supplies are slim, as they are now during deliveries of the first doses to states.Keith English, MD, Le Bonheur’s medical director of infectious diseases, said in the press release, “It’s important that our healthcare system is able to respond to the needs of our patients. This vaccine is one way we as healthcare workers can make sure we’re healthy and there for our patients when they need us.”Anne Schuchat, MD, director of the CDC’s National Center for Immunization and Respiratory Diseases, said, “Today we are beginning to turn the tide in the fight against the H1N1 flu virus. We are excited to begin to protect those who care for others.”Meanwhile, officials were also on hand to see healthcare workers at an Indianapolis health center receive some of the nation’s first pandemic flu doses, according to a press release from the Indiana State Department of Health (ISDH). On Oct 1 the state placed an order for its first shipment of 28,700 doses.Judy Monroe, MD, Indiana’s health commissioner, said she expects a substantial supply of the vaccine to arrive by mid October when officials will be targeting high-risk groups, including pregnant women, children from 6 months to 24 years old, people who take care of babies, and adults with underlying medical conditions.Some pediatrician offices are fielding dozens of calls from parents who want the pandemic vaccine for their children, the New York Times reported today.The virus is hitting younger age-groups the hardest, and federal officials are hoping pediatricians and schools can help get the vaccine quickly to children as soon as it is available. Influenza activity started spreading across the countries as school resumes.Most physicians don’t know exactly when they will receive their supplies, making it difficult to schedule appointments for young patients to be vaccinated.After it was inundated with calls from parents, a doctor’s office in Hartsdale, NY, added a new option on their answering machine that delivers a prerecorded message that the vaccine is not yet available, the Times reported.Kathryn Paterno, the clinic’s manager, told the Times, “People want it [the vaccine]. When they listen to news reports, they pick out bits and pieces—’swine flu, get it’—but they don’t quite comprehend that we don’t have it yet,” she said.The US government has ordered about 250 million doses of pandemic vaccine from five different producers. In mid September officials said the first wave of the vaccine would probably be 3.4 million doses of MedImmune’s nasal spray product, which were expected to reach providers the first week of October.Though health officials say the inhaled vaccine—approved for those ages 2 to 49—is a good option for healthy children, it is contraindicated for many in high risk people in the CDC’s priority groups, such as pregnant women and people with underlying medical conditions.The United States becomes the third country to begin pandemic vaccine immunization. China started immunizing students on Sep 21, and Australia began vaccinating its citizens on Sep 30.In early May, soon after the novel H1N1 virus was identified, an official from the World Health Organization predicted manufacturers would need 5 or 6 months to begin producing mass quantities of a vaccine.In late July, MedImmune announced it was getting high yields from its production of the pandemic H1N1 vaccine, even higher than for the seasonal flu version of its inhaled vaccine. Company officials said they had already made more than what the US government ordered, but said they faced a possible shortage of devices used to spray the vaccine into the nose.See also:Oct 5 Indiana State Department of Health press release
Nick Selbe is a senior majoring in communication. His column “Inside the 20s” runs Tuesdays. To comment on this story or to tell Nick that “In the Nick of Time” would be a better column name, visit dailytrojan.com or email him at [email protected] As the calendar approaches February, and with conference play well underway, the USC men’s basketball team reached a milestone this past week when it notched its first Pac-12 win of the Andy Enfield regime.The celebration was short-lived, though, as the Trojans were back to their losing ways in a loss to Stanford on Sunday, but I have to wonder if there was any real celebration in the first place.It’s not a good thing the team had to wait until its sixth attempt at a Pac-12 victory, especially given that USC lost its first five conference games by an average of 22.4 points, including a 107-73 bludgeoning at the hands of UCLA that was particularly hard to watch.After a solid non-conference showing that saw the team rack up nine wins against some respectable opponents, the Trojans appear to be outmatched in the Pac-12, which currently sits at No. 3 in the conference RPI rankings.Barring a dramatic turnaround, Enfield’s first season appears destined to end without a postseason berth, which would be the third consecutive season in which the Trojans failed to appear in the NCAA Tournament. No one really expected USC to qualify for the tournament at the season’s onset, so we show some patience and give Enfield time to turn the program around.The future looks somewhat bright for the Trojans, as Enfield has already had four commitments to the 2014 recruiting class, including the top-ranked point guard in California, Jordan McLaughlin, who chose USC over UCLA, Indiana and Kansas, among others. Joining McLaughlin next season will be three-star recruits in forwards Malik Price-Martin and Malik Marquetti, and center Jabari Craig.The Trojans’ class currently ranks No. 30 among all schools, according to ESPN.com, and USC will also have the services of sophomore guard Katin Reinhardt and sophomore forward Darion Clark, who both transferred to USC and will be available next year after sitting out this season.Reinhardt averaged 10.1 points per game and 29.2 minutes per game as a freshman at UNLV while shooting 35.1 percent from the 3-point line.Clark averaged 6.2 points and 4.6 rebounds per game as a freshman at Charlotte and will, at the very least, provide depth to a thin USC frontcourt.Though patience is being preached for the men’s team in its first year under a new coach, the same cannot be said for the USC women’s team. Under head Coach Cynthia Cooper-Dyke, the Women of Troy have shot up the Pac-12 standings and appear headed for their first NCAA Tournament since 2006.After an up-and-down start to the non-conference season, the Women of Troy have found their stride in Pac-12 play. Despite its 86-59 loss at Stanford on Monday, the team currently sits in second place in the Pac-12 and has already beaten two ranked conference foes in Cal and Colorado, and nearly beat a third in Arizona State.The Women of Troy have yet to drop a conference home game and have shown great poise in close games so far, especially in their 56-54 win over UCLA in the Pauley Pavilion.This success has the team sitting just outside the AP Top 25 Poll, which is an accomplishment in itself, considering how mightily the team struggled last season.The gap between the successes of the men’s and women’s team is staggering, and it’s tempting to criticize the men’s team when seeing how quickly success has come for the women.But I believe that the Women of Troy’s early triumphs are the exception rather than the rule — we should try not to grow impatient with how the men’s team has struggled in the early going.Both Enfield and Cooper-Dyke like to run fast-tempo offenses, and the players that Cooper-Dyke inherited might be a better fit for that system than Enfield’s. Junior guard Ariya Crook is a lightning bolt of energy and paces the Women of Troy’s attack.Crook currently leads the team in scoring with 16.1 points per game. Enfield’s starting point guard, senior Pe’Shon Howard, on the other hand, is not as explosive athletically compared to his competition and is only in his first year with the program after transferring from Maryland, where he averaged just 3.3 points per game last season and shot 29.1 percent from the field.Having a quick, experienced point guard is crucial to playing fast, and that is a luxury that Cooper-Dyke has that Enfield does not. Howard has been effective this season, especially considering the rushed manner in which he was forced to adapt to a new program, but might not be the type of floor general that Enfield needs for his system to work.Next season, with McLaughlin in the fold, perhaps Enfield can take a page out of Cooper-Dyke’s book and take USC toward the top half of the Pac-12 standings.Until then, it would be in Trojan fans’ best interest to remain invested in the men’s program, because as the women have shown this year, success can come quickly — and when you least expect it.